Programa de Pós-Graduação em Medicina: Ciências Médicas/Universidade Federal do Rio Grande do Sul, CEP 90035-003, Porto Alegre, Brazil.
J Clin Endocrinol Metab. 2011 May;96(5):1493-9. doi: 10.1210/jc.2010-2363. Epub 2011 Feb 23.
The relation between endothelial dysfunction (ED), glycemic control, and early type I diabetes mellitus (T1DM) is unclear.
The objective of the study was to evaluate the association of ED, glycemic control, and the duration of diabetes in T1DM.
This was a cross-sectional study.
The study was conducted at a public outpatient clinic.
Fifty-seven T1DM adolescents and 10 healthy age-matched controls participated in the study.
There were no interventions.
Endothelial function (ED) was evaluated by flow-mediated dilation (FMD) in the brachial artery after reactive hyperemia. Biochemical data, including HbA1c (glycohemoglobin), high-sensitivity C-reactive protein, lipids, and urinary albumin excretion were collected. Means of four HbA1c values collected at 3-month intervals in the first and second year before FMD analyses were obtained.
Mean FMD was decreased in T1DM compared with controls (P = 0.023), independent of age, smoking, hypertension, or dyslipidemia. Twenty-eight of 57 T1DM patients enrolled (49%) had ED. FMD was decreased in microalbuminuric (4.1%) compared with normoalbuminuric patients (10.1%, P = 0.01) and controls (14.6%, P < 0.001). FMD correlated inversely with mean second-year HbA1c (r = -0.426, P = 0.02), particularly in patients with less than 5 yr of T1DM (r = -0.61, P = 0.004). In these patients, high-sensitivity C-reactive protein was strongly correlated with mean first-year HbA1c (r = -0.66, P = 0.0003). In patients with more than 5 yr of T1DM, we found no significant correlations between ED and glycemic control.
Endothelial dysfunction is common in T1DM adolescents with less than 5 yr of disease. It is associated with duration of disease, microalbuminuria, and mean second-year HbA1c but not with mean first-year HbA1c. These data support the metabolic memory hypothesis.
内皮功能障碍(ED)、血糖控制与 1 型糖尿病(T1DM)早期之间的关系尚不清楚。
本研究旨在评估 ED、血糖控制与 T1DM 病程之间的相关性。
这是一项横断面研究。
研究在一家公立门诊诊所进行。
57 名 T1DM 青少年和 10 名年龄匹配的健康对照者参与了这项研究。
无干预措施。
通过肱动脉反应性充血后的血流介导扩张(FMD)评估内皮功能(ED)。收集生化数据,包括糖化血红蛋白(HbA1c)、高敏 C 反应蛋白、血脂和尿白蛋白排泄率。在 FMD 分析前的第 1 年和第 2 年,每 3 个月采集 4 次 HbA1c 值的平均值。
与对照组相比,T1DM 患者的平均 FMD 降低(P = 0.023),且独立于年龄、吸烟、高血压或血脂异常。57 名 T1DM 患者中有 28 名(49%)患有 ED。微量白蛋白尿患者(4.1%)的 FMD 低于正常白蛋白尿患者(10.1%,P = 0.01)和对照组(14.6%,P < 0.001)。FMD 与第 2 年平均 HbA1c 呈负相关(r = -0.426,P = 0.02),尤其是在病程少于 5 年的患者中(r = -0.61,P = 0.004)。在这些患者中,高敏 C 反应蛋白与第 1 年平均 HbA1c 密切相关(r = -0.66,P = 0.0003)。在病程超过 5 年的患者中,ED 与血糖控制之间无显著相关性。
病程少于 5 年的 T1DM 青少年中,内皮功能障碍很常见。它与病程、微量白蛋白尿和第 2 年平均 HbA1c 相关,但与第 1 年平均 HbA1c 无关。这些数据支持代谢记忆假说。